The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Initial phase 1b/2 study results of purinostat mesylate (PM) in combination with pomalidomide (POM) and low dexamethasone (DEX) in patients with RRMM.
 
Lijuan Chen
Employment - Zenitar
Leadership - Zenitar
Stock and Other Ownership Interests - Zenitar
Honoraria - Zenitar
Patents, Royalties, Other Intellectual Property - Chengdu Zenitar Biomedical Technology Co., Ltd.
Expert Testimony - Zenitar
 
Huili Cai
No Relationships to Disclose
 
Jin Lu
No Relationships to Disclose
 
Ting Niu
No Relationships to Disclose
 
Na Gao
No Relationships to Disclose
 
Zhihua Zhang
No Relationships to Disclose
 
Baijun Fang
No Relationships to Disclose
 
Zhenyu Yan
No Relationships to Disclose
 
Ke Tan
Employment - Zenitar
 
Rui Liang
Employment - Zenitar
 
Wei Zhang
Employment - Zenitar